SBRT Pre-operatively for Pancreatic Cancer

Study ID
NCT02308722

Study type
Interventional

Study phase
Phase 1

Study status
Completed

Trial Acronym

SPARC

Trial Summary

In this study the investigators are testing if the addition of Stereotactic Body Radiation therapy (SBRT) prior to surgery improves surgical outcome in patients with borderline resectable or resectable pancreatic cancer (BRPC).

More informations

Trial Starting Date

Apr 30,2015

Requirements

Gender All
Minimum age 16 Years
Maximum age N/A

Enrollement Limit